Targeted Therapies in Small Cell Lung Cancer: From Old Failures to Novel Therapeutic Strategies

Related Experiment Video

Updated: Jul 29, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.2K

Massimiliano Cani1, Valerio Maria Napoli1, Edoardo Garbo1

  • 1Department of Oncology, University of Turin, San Luigi Hospital, 10043 Orbassano, TO, Italy.

International Journal of Molecular Sciences
|May 27, 2023
PubMed

Insights

Small cell lung cancer (SCLC) treatment faces challenges, with limited survival benefits from current therapies. This review explores molecular pathways and targeted therapies for SCLC, offering hope for improved patient outcomes.

Area of Science:

  • Oncology
  • Thoracic Oncology
  • Molecular Biology

Background:

  • Small cell lung cancer (SCLC) management is challenging, with minimal survival improvements from existing treatments.
  • Immunotherapy offers marginal benefits for a subset of metastatic SCLC patients.
  • The treatment landscape for relapsed extended-disease SCLC (ED-SCLC) is largely underdeveloped.

Purpose of the Study:

  • To review the key molecular pathways implicated in SCLC development and progression.
  • To summarize current targeted therapies under investigation for SCLC patients.
  • To identify potential new therapeutic strategies for SCLC.

Main Methods:

  • Literature review of SCLC molecular pathways.
  • Analysis of clinical trial data for targeted therapies in SCLC.
  • Synthesis of current research on SCLC treatment strategies.

Main Results:

  • Several key signaling pathways driving SCLC have been identified.
  • Despite numerous failures, some targeted therapies show promising preliminary results.
  • Understanding molecular features is crucial for developing effective SCLC treatments.

Conclusions:

  • Targeted therapies represent a promising avenue for SCLC treatment development.
  • Further research into molecular pathways can guide the selection of effective targeted agents.
  • Advancements in understanding SCLC biology are essential for improving patient survival and clinical management.
Keywords:
SCLCsmall cell lung cancertargeted therapies

More Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.1K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
577